1308376-92-2

Basic information

• Product Name: (R)-3-(2-amino-2-(5-fluoro-2-methoxyphenyl)ethyl)-1-(2-fluoro-6-(trifluoromethyl) benzyl)-6-methyl-5-(4-(3-nitrobenzyl)piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione
• Synonyms: (R)-3-(2-amino-2-(5-fluoro-2-methoxyphenyl)ethyl)-1-(2-fluoro-6-(trifluoromethyl) benzyl)-6-methyl-5-(4-(3-nitrobenzyl)piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione
• CAS NO: 1308376-92-2
• Molecular Weight: 688.654
• Mol File: 1308376-92-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (R)-3-(2-amino-2-(5-fluoro-2-methoxyphenyl)ethyl)-1-(2-fluoro-6-(trifluoromethyl) benzyl)-6-methyl-5-(4-(3-nitrobenzyl)piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-3-(2-amino-2-(5-fluoro-2-methoxyphenyl)ethyl)-1-(2-fluoro-6-(trifluoromethyl) benzyl)-6-methyl-5-(4-(3-nitrobenzyl)piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione(1308376-92-2)
• EPA Substance Registry System: (R)-3-(2-amino-2-(5-fluoro-2-methoxyphenyl)ethyl)-1-(2-fluoro-6-(trifluoromethyl) benzyl)-6-methyl-5-(4-(3-nitrobenzyl)piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione(1308376-92-2)

Safety Data

• Hazardous Substances Data: 1308376-92-2(Hazardous Substances Data)

Upstream product

• 1308378-32-6 1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methyl-5-(4-(3-nitrobenzyl)piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione 
• 1308380-33-7 1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methyl-5-(piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione 
• 1308380-31-5 5-(4-benzyl-piperazin-1-yl)-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione 
• 830346-48-0 5-bromo-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4-(1H,3H)-dione 

Relevant articles and documents

Synthesis and biological evaluation of 3-(2-aminoethyl) uracil derivatives as gonadotropin-releasing hormone (GnRH) receptor antagonists

We investigated a series of uracil analogues by introducing various substituents on the phenyl ring of the N-3 aminoethyl side chain and evaluated their antagonistic activity against human gonadotropin-releasing hormone (GnRH) receptors. Analogues with su

GONADOTROPIN RELEASING HORMONE RECEPTOR ANTAGONISTS, MANUFACTURING METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

Disclosed are compounds useful as gonadotropin-releasing hormone ("GnRH") receptor antagonist.